FRE.AX
Price:
$0.053
Market Cap:
$13.03M
Firebrick Pharma Limited engages in the development and commercialization of nasal spray treatment for the common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.
Industry
Drug Manufacturers - General
IPO Date
2022-01-27
Stock Exchange
ASX
Ticker
FRE.AX
According to Firebrick Pharma Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 12.05M. This represents a change of 18.34% compared to the average of 10.18M of the last 4 quarters.
The mean historical Enterprise Value of Firebrick Pharma Limited over the last ten years is 48.47M. The current 12.05M Enterprise Value has changed 2.39% with respect to the historical average. Over the past ten years (40 quarters), FRE.AX's Enterprise Value was at its highest in in the December 2020 quarter at 89.58M. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.
Average
48.47M
Median
37.60M
Minimum
8.66M
Maximum
89.45M
Discovering the peaks and valleys of Firebrick Pharma Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 39.13%
Maximum Annual Enterprise Value = 89.45M
Minimum Annual Increase = -63.92%
Minimum Annual Enterprise Value = 8.66M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 12.05M | 39.13% |
| 2024 | 8.66M | -63.92% |
| 2023 | 24.01M | -36.15% |
| 2022 | 37.60M | -52.17% |
| 2021 | 78.61M | -12.12% |
| 2020 | 89.45M | 0.61% |
The current Enterprise Value of Firebrick Pharma Limited (FRE.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.91M
5-year avg
32.19M
10-year avg
48.47M
Firebrick Pharma Limited’s Enterprise Value is less than Althea Group Holdings Limited (21.57M), less than Nanollose Limited (13.61M), greater than Patrys Limited (10.39M), less than MedAdvisor Limited (21.10M), less than Neurotech International Limited (14.81M), greater than Tissue Repair Ltd (7.63M), less than ImExHS Limited (16.66M), less than BTC Health Limited (18.60M), less than Immuron Limited (13.02M), less than Avecho Biotechnology Limited (20.83M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 21.57M | $16.91M | |
| 13.61M | $14.19M | |
| 10.39M | $11.14M | |
| 21.10M | $14.00M | |
| 14.81M | $17.84M | |
| 7.63M | $19.95M | |
| 16.66M | $17.79M | |
| 18.60M | $19.22M | |
| 13.02M | $15.73M | |
| 20.83M | $26.70M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Firebrick Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Firebrick Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Firebrick Pharma Limited's Enterprise Value?
What is the highest Enterprise Value for Firebrick Pharma Limited (FRE.AX)?
What is the 3-year average Enterprise Value for Firebrick Pharma Limited (FRE.AX)?
What is the 5-year average Enterprise Value for Firebrick Pharma Limited (FRE.AX)?
How does the current Enterprise Value for Firebrick Pharma Limited (FRE.AX) compare to its historical average?